Grandis Biotech

Grandis Biotech Overview

Status Acquired/​Merged
Latest Deal Type M&A
Latest Deal Amount $15.7M
Latest Deal Amount

Grandis Biotech General Information

Description

Developer of human growth hormone (rhGH) intended to treat growth retardation in adolescents. The company's human growth hormones include liquid formulation to supersede the standard freeze-dried powder enables its clients with engineered medicinal products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • Gruenstrasse 18
  • March
  • 79232 Freiburg
  • Germany
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Grandis Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 10-Apr-2000 $15.7M 000.00 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue

Grandis Biotech Former Investors (1)

To view Grandis Biotech‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Wellington Partners Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial